Regulatory information 

Over the years, the required knowledge base for the regulatory affairs profession has increased in complexity, breadth and depth. The Food and Drug Administration (FDA) has expanded its compliance requirements to align with internationally harmonized requirements from the European Union (EU), International Conference for Harmonization (ICH), and others.

Professional competencies

Today’s regulatory professional must have competencies in product approval requirements, quality system requirements, product design and engineering requirements, and more detailed topics depending on the criticality and type of device or drug, and affected geographies. Read more about professional regulatory competencies.

Our regulatory services

Whatever your regulatory needs, Medical Devices and Pharma provides regulatory services to companies in the medical device and pharmaceutical industries. So if you find that you would like to add a regulatory professional to your team, or a team of regulatory professionals, we can help.

Laws, regulations and regulatory documentation  can be difficult to understand and interpret, especially for companies and individuals that are new to the industry or not otherwise familiar with legal requirements and guidelines. Add to that the need to stay up to date with current regulatory news, information, and trends, and the complexity of the profession becomes even more daunting.

Bookmark this page

We recommend that you bookmark this space, because Medical Devices and Pharma will provide updates on regulatory news and events, as well as solid interpretation, analysis, and opinions to help you navigate through the national and international regulatory environments.

510(k) Submissions

Let’s connect

Consider us as a colleague and advisor if you are planning a new product or product design change, are not completely sure about compliance requirements, or have regulatory enforcement issues that you need to resolve. Some examples of the services we provide follow. And if you have any questions about these or other regulatory areas of expertise, please contact us.

When Apparel Becomes a Medical Device

Lessons from FDA’s Breast Binder Warning Letters In December 2025, the FDA issued warning letters to several companies selling breast binders and chest compression garments online. The agency concluded that marketing claims on company websites, like statements about...

read more

Testosterone Regulation Takes a Sharp Turn

Why FDA’s December Panel Raises Red Flags Regulatory Analysis The FDA’s regulation of testosterone therapy has long been a model of cautious, evidence-based policymaking. For more than a decade, the agency maintained a consistent position: testosterone was approved...

read more

Regulatory Information

When Apparel Becomes a Medical Device

Lessons from FDA’s Breast Binder Warning Letters In December 2025, the FDA issued warning letters to several companies selling breast binders and chest compression garments online. The agency concluded that marketing claims on company websites, like statements about...

Testosterone Regulation Takes a Sharp Turn

Why FDA’s December Panel Raises Red Flags Regulatory Analysis The FDA’s regulation of testosterone therapy has long been a model of cautious, evidence-based policymaking. For more than a decade, the agency maintained a consistent position: testosterone was approved...

Invisible Outbreak of Contaminated Supplement Ingredients

Contaminated Products Distributed Nationwide  How a contaminated Moringa shipment was spread across the U.S. supplement market, and why there were no additional recalls.  Sam’s Club announced a recall of its Member’s Mark Super Greens powder in late October 2025 due...